Literature DB >> 1583334

Prevalence of antibody to Borrelia burgdorferi by indirect fluorescent antibody assay, ELISA, and western immunoblot in healthy adults in Wisconsin and Arizona.

M M Huycke1, D D D'Alessio, J J Marx.   

Abstract

The prevalence of antibody to Borrelia burgdorferi in healthy adults from Wisconsin and Arizona was determined by indirect fluorescent antibody assay (IFA), ELISA, and Western immunoblotting. A total of 301 sera from adult volunteer blood donors were collected from three areas of Wisconsin and compared with 49 consecutive anonymous adult volunteer donor sera from Tucson, Arizona, an area without reported Lyme borreliosis. Regional differences in seropositivity were found for Western immunoblotting (34[11%] of 301 from Wisconsin and none of 49 from Tucson; P less than .01) but not IFA or ELISA. No correlation was found among Western immunoblotting and IFA or ELISA results. For persons living in Madison or Milwaukee, Wisconsin (cities not endemic for Lyme borreliosis), 19 (86%) of 22 with a positive Western blot, but only 12 (48%) of 25 with a positive IFA or ELISA, had a significant exposure risk to B. burgdorferi-infected Ixodes dammini (odds ratio, 6.9; 95% confidence interval, 1.4-43.5). Western blot results were consistent with epidemiologic exposure to B. burgdorferi and implied frequent asymptomatic infection among healthy adults living in or visiting areas endemic for Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583334     DOI: 10.1093/infdis/165.6.1133

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Seroprevalence of Lyme borreliosis in forestry workers from Brandenburg, Germany.

Authors:  P M Rath; B Ibershoff; A Mohnhaupt; J Albig; B Eljaschewitsch; D Jürgens; I Horbach; F J Fehrenbach
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

2.  Antibodies to Borrelia burgdorferi in European populations.

Authors:  J Gutiérrez; M Guerrero; F Nuñez; M J Soto; G Piédrola; M C Maroto
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Evaluation of a passive hemagglutination assay as screening test and of a recombinant immunoblot as confirmatory test for serological diagnosis of Lyme disease.

Authors:  A Hamann-Brand; M Flondor; V Brade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

4.  Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.

Authors:  M Dunne; B K al-Ramadi; S W Barthold; R A Flavell; E Fikrig
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

5.  An OspA antigen-capture enzyme-linked immunosorbent assay for detecting North American isolates of Borrelia burgdorferi in larval and nymphal Ixodes dammini.

Authors:  T R Burkot; R A Wirtz; B Luft; J Piesman
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Lyme disease: a search for a causative agent in ticks in south-eastern Australia.

Authors:  R C Russell; S L Doggett; R Munro; J Ellis; D Avery; C Hunt; D Dickeson
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

7.  Three-year study of antibody to Borrelia burgdorferi in southern Spain.

Authors:  J Gutierrez; M C Maroto; A De la Higuera; M Guerrero; E Padilla; G Piédrola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

8.  Evaluation of nine serological tests for diagnosis of Lyme borreliosis.

Authors:  M K Nohlmans; A A Blaauw; A E van den Bogaard; C P van Boven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

9.  Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto.

Authors:  R Kaiser; S Rauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

10.  Introduction of IgM testing for the diagnosis of acute Lyme borreliosis: a study of the benefits, limitations and costs.

Authors:  Greg Joyner; Sally Mavin; Rachel Milner; Chin Lim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-28       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.